Таблица 2. Количество извлеченных документов с упоминаниями различных способов иммунотерапии онкологических заболеваний.
|
|
Effector or APC |
Count of extracted documents |
|||
|
Total |
Humans |
Other animals |
Clinical trials |
||
|
Active immunotherapy (cell vaccine) |
Antigen loaded dendritic cells (DC vaccine) |
1978 |
1200 |
778 |
298 |
|
Dendritomas |
23 |
13 |
10 |
2 |
|
|
Antigen-presenting B-cells (AP B-cells) |
1 |
1 |
0 |
0 |
|
|
Inactivated tumor cells |
61 |
54 |
7 |
23 |
|
|
Passive (adoptive) immunotherapy |
Tumor-infiltrating T-cells (TIL) |
297 |
217 |
80 |
44 |
|
Chimeric antigen receptor T-cells (CAR-T-cells) |
136 |
92 |
44 |
14 |
|
|
Redirected TCR T-cells (reTCR-T-cells) |
11 |
10 |
1 |
0 |
|
|
Lymphokine activated killers (LAK) |
126 |
92 |
34 |
18 |
|
|
Cytokine-induced killers (CIK) |
106 |
78 |
28 |
17 |
|
|
Antibody dependent cell-mediated cytotoxicity (ADCC) |
7 |
6 |
1 |
1 |
|
|
Chimeric antigen receptor NK-cells (CAR-NK-cells) |
1 |
1 |
0 |
0 |
|